Single domain antibodies targeting pathological tau protein: Influence of four IgG subclasses on efficacy and toxicity-Reference-Cited by-同舟云学术

Single domain antibodies targeting pathological tau protein: Influence of four IgG subclasses on efficacy and toxicity

Published:2022-10 Issue: Volume:84 Page:104249
ISSN:2352-3964
Container-title:eBioMedicine
language:en
Short-container-title:eBioMedicine

Author:

Congdon Erin E.,Pan Ruimin,Jiang Yixiang,Sandusky-Beltran Leslie A.,Dodge Andie,Lin Yan,Liu Mengyu,Kuo Min-Hao,Kong Xiang-Peng^ORCID,Sigurdsson Einar M.

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference82 articles.

1. Current status of clinical trials on tau immunotherapies;Ji;Drugs,2021

2. Tau immunotherapies: lessons learned, current status and future considerations;Sandusky-Beltran;Neuropharmacology,2020

3. Targeting tau only extracellularly is likely to be less efficacious than targeting it both intra- and extracellularly;Congdon;Semin Cell Dev Biol,2022

4. Advances and considerations in AD tau-targeted immunotherapy;Bittar;Neurobiol Dis,2020

5. Passive immunotherapies targeting Abeta and tau in Alzheimer's disease;Plotkin;Neurobiol Dis,2020

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-tau single domain antibodies clear pathological tau and attenuate its toxicity and related functional defects;Cell Death & Disease;2024-07-30

2. Single-domain antibody-based protein degrader for synucleinopathies;Molecular Neurodegeneration;2024-05-31

3. Exploring the effectiveness and safety profile of TAU protein antibodies as potential therapies for alzheimer's disease: a comprehensive review;Asia-Pacific Journal of Surgical & Experimental Pathology;2024-04-08

4. Development of a pan‐tau multivalent nanobody that binds tau aggregation motifs and recognizes pathological tau aggregates;Biotechnology Progress;2024-04-03

5. Single-Domain Antibody-Based Protein Degrader for Synucleinopathies;2024-03-13